Navigation Links
Ready-To-Use Products Spur the European Tissue Sealants and Topical Hemostats Markets, Says Frost & Sullivan
Date:1/27/2009

LONDON, Jan. 27 /PRNewswire/ -- Cannibalisation, high market complexity and significant barriers to entry are all influencing the European tissue sealants and topical hemostats markets. However, the increase in complex surgeries and anticipated technology innovations are continuing to drive growth. Ready-to-use products will ensure market expansion.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), European Tissue Sealants and Topical Hemostats Market, finds that the markets earned revenues of $338.5 million in 2007 and estimates this to reach $645.6 million in 2014.

"The European tissue sealants and topical hemostats markets are driven primarily by the need for quicker and more effective surgeries," notes the Frost & Sullivan analyst. "Additionally, combination products and ready-to-use patches will invigorate market revenues."

The ability to reduce post-operative times will also boost the sale of ready-to-use patches. In addition, fibrin sealants should expand beyond typical wound care applications to be used as drug delivery mechanisms and in adhesion prevention, thus increasing the scope of the market in the future.

However, the dominance of a few large participants will deter the entry of new competitors with innovative products. Furthermore, the lack of proper product positioning will trigger cannibalisation in the market.

"There are high entry barriers in the European tissue sealants and topical hemostats markets," Frost & Sullivan explains. "Apart from domination by a handful of large companies, regulatory issues and the long gestation period also affect the entry of prospective participants. The complex nature of the market itself poses a challenge for its growth."

Industry participants should concentrate on gaining clarity in product positioning and achieving product differentiation in the minds of end users. Diversification into untapped markets, manufacturing ready-to-use products and entering into strategic alliances will be some of the keys to survival in these markets.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the European tissue sealants and topical hemostats market, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.

European Tissue Sealants and Topical Hemostats Market is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: European Urinary Incontinence Devices Market, European Ophthalmic Surgical Devices Market, European Insulin Delivery Devices Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit http://www.frost.com.

European Tissue Sealants and Topical Hemostats Market

M2F8

    Contact:
    Katja Feick
    Corporate Communications - Europe
    P: +49 (0) 69 77 0 33 43
    E: katja.feick@frost.com
   http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
3. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
4. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
5. Why Are Most Health & Wellness Products Doomed to Failure?
6. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
7. Consumer Specialty Products Association Highly Critical of NRDC Study on Home Air Fresheners
8. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
9. New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals
10. UniCare Introduces Consumer-Driven Health Products to Give Consumers a Bigger Role in Health Care Decisions
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology: